Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IsoTC: Balanced Fluids in Severe Head Trauma
NCT00847977Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Oct 2008
- Primary completion
- Oct 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sterofundin, hydroxyethyl starch 130/0.42 in traumatic brain injury (TBI), sponsored by CHU de Nantes. Started Oct 2008; status: terminated.
02
Drugs
sterofundinhydroxyethyl starch 130/0.42
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00847977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847977.